Lu AF21934, a positive allosteric modulator of mGlu4 receptors, reduces the harmaline-induced hyperactivity but not tremor in rats.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Neuropharmacology

• Publication date

  2014-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.neuropharm.2014.03.018PMID 24726309
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anxiolytic- but not antidepressant-like activity of Lu AF21934, a novel, selective positive allosteric modulator of the mGlu₄ receptor.

  2013influential reference
• Seeking a unified framework for cerebellar function and dysfunction: from circuit operations to cognition

  2013cited by this paper
• The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT1A signalling

  2013cited by this paper
• A partial lesion of the substantia nigra pars compacta and retrorubral field decreases the harmaline-induced glutamate release in the rat cerebellum.

  2013cited by this paper
• The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT1A signalling

  2013cited by this paper
• Synergy between L-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: implications for Parkinson's disease treatment and dyskinesia.

  2013influential reference
• The antipsychotic‐like effects of positive allosteric modulators of metabotropic glutamate mGlu4 receptors in rodents

  2013cited by this paper
• Stimulation within the cuneate nucleus suppresses synaptic activation of climbing fibers

  2013cited by this paper
• Genetics of essential tremor.

  2012cited by this paper
• Metabolic pathways of the psychotropic-carboline alkaloids, harmaline and harmine, by liquid chromatography/mass spectrometry and NMR spectroscopy.

  2012cited by this paper
• Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia.

  2012cited by this paper
• Widespread State-Dependent Shifts in Cerebellar Activity in Locomoting Mice

  2012cited by this paper
• A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential

  2012influential reference
• 6-OHDA injections into A8-A9 dopaminergic neurons modelling early stages of Parkinson's disease increase the harmaline-induced tremor in rats.

  2012influential reference
• Modulation of glutamate release from parallel fibers by mGlu4 and pre‐synaptic GABAA receptors

  2012cited by this paper
• Lesion of the Cerebellar Noradrenergic Innervation Enhances the Harmaline-Induced Tremor in Rats

  2011influential reference
• The effect of memantine in harmaline-induced tremor and neurodegeneration.

  2011cited by this paper
• Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease

  2010cited by this paper
• Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson’s disease treatment

  2009cited by this paper
• Role of the metabotropic glutamate receptor subtype 1 in the Harmaline-induced tremor in rats

  2009influential reference
• Pharmacological characterization of harmaline-induced tremor activity in mice.

  2009influential reference
• Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism

  2009influential reference
• Depression of excitatory transmission at PF‐PC synapse by group III metabotropic glutamate receptors is provided exclusively by mGluR4 in the rodent cerebellar cortex

  2008cited by this paper
• Rodent models of tremor

  2008influential reference
• Synthesis and biological evaluation of 1-amino-2-phosphonomethylcyclopropanecarboxylic acids, new group III metabotropic glutamate receptor agonists.

  2007cited by this paper
• Update on pathogenesis and treatment of essential tremor

  2007cited by this paper
• Genetics of essential tremor.

  2007cited by this paper
• Effects of harmaline on anxiety-related behavior in mice.

  2005cited by this paper
• Altered glutamate and GABA release within thalamocortical circuitry in metabotropic glutamate receptor 4 knockout mice.

  2005cited by this paper
• Neuropharmacological characterization of local ibogaine effects on dopamine release

  2005cited by this paper
• Imaging parallel fiber and climbing fiber responses and their short-term interactions in the mouse cerebellar cortex in vivo.

  2004cited by this paper
• Harmaline-induced climbing fiber activation causes amino acid and peptide release in the rodent cerebellar cortex and a unique temporal pattern of Fos expression in the olivo-cerebellar pathway

  2004influential reference
• Group III Metabotropic Glutamate Receptor-Mediated Modulation of the Striatopallidal Synapse

  2003cited by this paper
• Distribution and synaptic localisation of the metabotropic glutamate receptor 4 (mGluR4) in the rodent CNS.

  2002influential reference
• Stimulus-dependent activation of c-Fos in neurons and glia in the rat cerebellum.

  2002influential reference
• Effects of harmine on dopamine output and metabolism in rat striatum: role of monoamine oxidase-A inhibition

  2001cited by this paper
• A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor.

  2001cited by this paper
• Concurrent quantification of tremor and depression of locomotor activity induced in rats by harmaline and physostigmine

  2001influential reference
• Differential expression of c‐Fos following administration of two tremorgenic agents: harmaline and oxotremorine

  2000cited by this paper
• Immunohistochemical localization of N-methyl-D-aspartate receptor NR1, NR2A, NR2B and NR2C/D subunits in the adult mammalian cerebellum.

  2000cited by this paper
• Immunohistochemical localization of subtype 4a metabotropic glutamate receptors in the rat and mouse basal ganglia

  1999cited by this paper
• Expression of metabotropic glutamate receptor subtype mRNA (mGluR1-8) in human cerebellum.

  1999influential reference
• Animal models of tremor

  1999cited by this paper
• Systemic harmaline blocks associative and motor learning by the actions of the inferior olive

  1998cited by this paper
• Inhibition of monoamine oxidase A by beta-carboline derivatives.

  1997cited by this paper
• Inhibition of Monoamine Oxidase A by β-Carboline Derivatives

  1997influential reference
• Research report Harmaline-induced tremor and impairment of learning are both blocked by dizocilpine in the rabbit

  1997influential reference
• Effects of 7-nitroindazole, NG-nitro-L-arginine, and D-CPPene on harmaline-induced postural tremor, N-methyl-D-aspartate-induced seizures, and lisuride-induced rotations in rats with nigral 6-hydroxydopamine lesions.

  1996cited by this paper
• Presynaptic localization of a metabotropic glutamate receptor, mGluR4a, in the cerebellar cortex: a light and electron microscope study in the rat.

  1996cited by this paper
• EMG analysis of harmaline-induced tremor in normal and three strains of mutant mice with Purkinje cell degeneration and the role of the inferior olive.

  1995cited by this paper
• Interaction of β-carbolines with central dopaminergic transmission in mice: structure-activity relationships

  1995cited by this paper
• Interaction of beta-carbolines with central dopaminergic transmission in mice: structure-activity relationships.

  1995cited by this paper
• Localization of AMPA receptors in the hippocampus and cerebellum of the rat using an anti-receptor monoclonal antibody.

  1992cited by this paper
• Aspartate-like and glutamate-like immunoreactivities in the inferior olive and climbing fibre system: a light microscopic and semiquantitative electron microscopic study in rat and baboon (Papio anubis).

  1990cited by this paper
• Benzodiazepine receptors are involved in tabernanthine-induced tremor: in vitro and in vivo evidence.

  1987cited by this paper
• The olivocerebellar system

  1983cited by this paper
• Benzodiazepine antagonism by harmane and other β-carbolines in vitro and in vivo

  1981cited by this paper
• Benzodiazepine antagonism by harmane and other beta-carbolines in vitro and in vivo.

  1981influential reference
• The olivocerebellar system. I. Delayed and slow inhibitory effects: an overlooked salient feature of cerebellar climbing fibers.

  1980cited by this paper
• Harmaline-induced rhythmic activity of cerebellar and lower brain stem neurons.

  1971cited by this paper
• Psychotropic properties of the harmala alkaloids

  1967cited by this paper
• Ethnopharmacologic Search for Psychoactive Drugs

  1967cited by this paper

• Synergistic anxiolytic-like effect of CPPG and harmaline in non-stressed and acute restraint stress (ARS) mice.

  2025cites this paper
• Targeting mGluR group III for the treatment of neurodegenerative diseases.

  2023cites this paper
• Neuroscience and Actometry: an example of the benefits of the precise measurement of behavior.

  2022cites this paper
• Pramipexole Reduces zif-268 mRNA Expression in Brain Structures involved in the Generation of Harmaline-Induced Tremor

  2020cites this paper
• Inhibition of excessive glutamatergic transmission in the ventral thalamic nuclei by a selective adenosine A1 receptors agonist, 5'-chloro-5'-deoxy-(±)-ENBA underlies its tremorolytic effect in the harmaline-induced model of Essential Tremor.

  2020cites this paper
• Challenges in the Discovery and Optimization of mGlu2/4 Heterodimer Positive Allosteric Modulators

  2019cites this paper
• Discovery and Development of Non-Dopaminergic Agents for the Treatment of Schizophrenia: Overview of the Preclinical and Early Clinical Studies.

  2019cites this paper
• An Update On The Neurochemistry Of Essential Tremor.

  2018cites this paper
• Tremorolytic effect of 5′‐chloro‐5′‐deoxy‐(±)‐ENBA, a potent and selective adenosine A1 receptor agonist, evaluated in the harmaline‐induced model in rats

  2017cites this paper
• Behavioral Changes Over Time Following Ayahuasca Exposure in Zebrafish

  2017cites this paper
• Pramipexole at a Low Dose Induces Beneficial Effect in the Harmaline‐induced Model of Essential Tremor in Rats

  2016cites this paper
• Development of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize the thermoregulatory effects of serotonergic drugs in mice

  2016cites this paper
• Modification of 5-methoxy-N, N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms

  2016cites this paper
• Apomorphine enhances harmaline-induced tremor in rats

  2015cites this paper
• Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors.

  2015cites this paper
• Identification of Positive Allosteric Modulators VU0155094 (ML397) and VU0422288 (ML396) Reveals New Insights into the Biology of Metabotropic Glutamate Receptor 7

  2014cites this paper